Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of 1PC002 (Pitavastatin) vs Atorvastatin in Hypercholesterolemia
NCT01710007Phase 3Completed
- Sponsor
- Orient Pharma Co., Ltd.
- Start
- Nov 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin in hypercholesterolemia, combined dyslipidemia, sponsored by Orient Pharma Co., Ltd.. Started Nov 2011; status: completed.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemiacombined dyslipidemia
Beyond the preview
Go deeper on NCT01710007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710007.